New Cervical Cancer Treatment Reduces Death Risk by 40%

A study reveals significant survival benefits from a revised treatment regimen involving induction chemotherapy before chemoradiation.

Researchers at University College London led a decade-long study involving 500 patients from five countries.
The new regimen involves a short course of chemotherapy before the standard chemoradiation treatment.
Results show a 40% reduction in death risk and a 35% decrease in cancer recurrence within five years.
The treatment uses existing, affordable drugs and can be quickly implemented globally.
Experts urge the widespread adoption of this regimen, highlighting its potential to significantly improve survival rates.